John M. Walshe

John M. Walshe's AcademicInfluence.com Rankings

John M. Walshe

Philosophy

#4356

World Rank

#6838

Historical Rank

Logic

#1835

World Rank

#2683

Historical Rank

philosophy Degrees

John M. Walshe

Biology

#5678

World Rank

#8215

Historical Rank

Biochemistry

#691

World Rank

#791

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

John M. Walshe's Degrees

PhD Biochemistry University of California, Berkeley
Doctorate Medicine Stanford University

Why Is John M. Walshe Influential?

(Suggest an Edit or Addition)

(See a Problem?)

John M. Walshe's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Penicillamine, a new oral therapy for Wilson's disease. (1956) (640)
The Wilson disease gene: spectrum of mutations and their consequences (1995) (555)
TREATMENT OF WILSON'S DISEASE WITH TRIENTINE (TRIETHYLENE TETRAMINE) DIHYDROCHLORIDE (1982) (327)
Wilson's disease; new oral therapy. (1956) (221)
Wilson's disease: the problem of delayed diagnosis. (1992) (177)
Cranial MR imaging in Wilson's disease. (1996) (174)
Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride. (1973) (171)
Benign recurrent intrahepatic "obstructive" jaundice. (1959) (171)
Chelation treatment of neurological Wilson's disease. (1993) (141)
Management of penicillamine nephropathy in Wilson's disease: a new chelating agent. (1969) (133)
Disturbances of aminoacid metabolism following liver injury; a study by means of paper chromatography. (1953) (132)
Wilson's disease. An analysis of the cranial computerized tomographic appearances found in 60 patients and the changes in response to treatment with chelating agents. (1981) (125)
Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically (2003) (119)
DANGERS OF NON-COMPLIANCE IN WILSON'S DISEASE (1986) (105)
Abdominal malignancies in patients with Wilson's disease. (2003) (100)
Wilson's Disease (1962) (100)
Observations on the symptomatology and pathogenesis of hepatic coma. (1951) (95)
DIAGNOSIS AND TREATMENT OF PRESYMPTOMATIC WILSON'S DISEASE (1988) (94)
Wilson's disease and epilepsy. (1988) (94)
Haplotypes and mutations in Wilson disease. (1995) (92)
Arthropathy of Wilson's disease. Study of clinical and radiological features in 32 patients. (1977) (92)
A study of the caeruloplasmin concentrations found in 75 patients with Wilson's disease, their kinships and various control groups. (1979) (91)
Treatment of Wilson's disease with penicillamine. (1960) (82)
The pathogenesis of cystinuria. II. Polarographic studies of the metabolism of sulfur-containing amino-acids. (1954) (81)
Wilson's disease presenting with features of hepatic dysfunction: a clinical analysis of eighty-seven patients. (1989) (81)
Pregnancy in Wilson's disease. (1977) (72)
Methyl mercaptan in relation to foetor hepaticus. (1955) (71)
The management of pregnancy in Wilson's disease treated with trientine. (1986) (71)
Cause of death in Wilson disease (2007) (70)
The physiology of copper in man and its relation to Wilson's disease. (1967) (69)
Penicillamine: The treatment of first choice for patients with Wilson's disease (1999) (66)
History of Wilson's disease: 1912 to 2000 (2006) (61)
Caeruioplasmin in liver disease. A diagnostic pitfall. (1962) (61)
Wilson's disease: some current concepts. (1961) (57)
Clinical correlation of brain MRI and MRS abnormalities in patients with Wilson disease (2004) (56)
BILIARY EXCRETION OF COPPER IN WILSON'S DISEASE (1980) (55)
Zinc-induced deterioration in Wilson's disease aborted by treatment with penicillamine, dimercaprol, and a novel zero copper diet. (1995) (54)
Copper: its role in the pathogenesis of liver disease. (1984) (52)
Haplotype studies in Wilson disease. (1994) (50)
The story of penicillamine: A difficult birth (2003) (49)
Penicillamine and pyridoxine requirements in man. (1966) (44)
Studies with radioactive copper (64Cu and 67Cu) in relation to the natural history of Wilson's disease. (1967) (44)
Studies with 35S-labelled DL-penicillamine in patients with Wilson's disease. (1971) (43)
Twenty‐four novel mutations in Wilson disease patients of predominantly European ancestry (2005) (40)
Wilson's disease: Yesterday, today, and tomorrow (1988) (40)
The pattern of the whole body distribution of radioactive copper (67Cu, 64Cu) in Wilson's Disease and various control groups. (1977) (38)
Effect of treatment of Wilson's disease on natural history of haemochromatosis (1998) (38)
Treatment of Wilson's disease: the historical background. (1996) (38)
The conquest of Wilson's disease. (2009) (36)
Wilson's disease (1969) (35)
REVERSIBLE PANCYTOPENIA SECONDARY TO TREATMENT WITH TETRATH10‐MOLYBDATE (1986) (35)
Effects of penicillamine and dimercaprol on turnover of copper in patients with Wilson's disease. (1958) (33)
The acute haemolytic syndrome in Wilson's disease--a review of 22 patients. (2013) (32)
BRAIN COPPER IN WILSON'S DISEASE (1987) (30)
Diagnostic significance of reduced serum caeruloplasmin concentration in neurological disease (2005) (30)
Preparation of triethylenetetramine dihydrochloride for the treatment of Wilson's disease. (1972) (30)
Penicillamine and the SLE syndrome. (1981) (28)
Serum 'free' copper in Wilson disease. (2012) (28)
Research evidence and the individual patient. (2003) (26)
Current views on the pathogenesis and treatment of Wilson's disease. (1959) (25)
Primary carcinoma of the liver following viral hepatitis report of two cases. (1952) (25)
Not Wilson's disease: a review of misdiagnosed cases. (1995) (25)
Studies with radioactive copper (64Cu and 67Cu): abdominal scintiscans in patients with Wilson's disease. (1969) (24)
Liver copper concentration in Wilson‘s disease: Effect of treatment with ‘anti‐copper’ agents (1990) (23)
Studies with radioactive copper ( 64 Cu and 67 Cu); the incorporation of radioactive copper into caeruloplasmin in Wilson's disease and in primary biliary cirrhosis. (1971) (22)
Studies on the toxicity of copper. II. The behaviour of microsomal membrane ATPase of the pigeon’s brain tissue to copper and some other metallic substances (1966) (22)
The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease. (2011) (22)
STUDIES WITH RADIOCOPPER (64CU) IN WILSON'S DISEASE: THE LIVER/THIGH RATIO. (1964) (22)
Effect of penicillamine on failure of renal acidification in Wilson's disease. (1968) (21)
Disturbances of cystine metabolism in liver disease. (1955) (19)
Urinary excretion of peptides and of hydroxyproline in Wilson's disease. (1976) (18)
Studies on the toxicity of copper. I. The toxic action of copper in vivo and in vitro (1966) (18)
Monitoring copper in Wilson's disease. (2010) (18)
Tutankhamun: Klinefelter's or Wilson's? (1973) (17)
Copper Content of Hair in Normal Families and those with Wilson's Disease (1965) (17)
Treatment of Wilson's disease with zinc sulphate. (1984) (17)
The management of Wilson's disease with trienthylene tetramine 2HC1 (Trien 2HC1). (1979) (17)
The natural history of malignant granuloma of the nose. (1958) (16)
Effect of penicillamine on serum iron. (1965) (16)
Penicillamine Neurotoxicity: An Hypothesis (2011) (15)
Central nervous system regeneration. (2014) (15)
Toxic reactions to penicillamine in patients with Wilson's disease. (1968) (14)
History of Wilson disease: a personal account. (2017) (14)
INTERRUPTION OF THE TRYPTOPHAN‐NICOTINIC ACID PATHWAY BY PENICILLAMINE‐INDUCED PYRIDOXINE DEFICIENCY IN PATIENTS WITH WILSON'S DISEASE AND IN EXPERIMENTAL ANIMALS (1969) (13)
Uptake of radiocopper by the liver. A study of patients with Wilson's disease and various control groups. (1963) (13)
The urinary excretion of radiocopper in presymptomatic and symptomatic Wilson's disease, heterozygotes and controls: its significance in diagnosis and management. (1978) (13)
Echinococcosis alveolaris of the liver. (1954) (13)
Proceedings: The musculoskeletal features of Wilson's disease: a clinical, radiological, and serological survey. (1975) (12)
Unithiol in Wilson's disease. (1985) (11)
Studies on the oxidase properties of ceruloplasmin: factors in normal and Wilson's-disease serum affecting oxidase activity. (1963) (11)
Wilson's Disease: Major Problems in Internal Medicine, vol 23 (1986) (11)
WILSON'S DISEASE PATIENTS CAN BE DECOPPERED (1989) (11)
Brief Observations on the Management of Wilson's Disease (1977) (11)
The eye in Wilson disease. (1976) (11)
ENDOGENOUS COPPER CLEARANCE IN WILSON'S DISEASE: A STUDY OF THE MODE OF ACTION OF PENICILLAMINE. (1964) (11)
Hepatolenticular degeneration (Wilson's disease). (1957) (10)
The effect of certain chelating compounds on the urinary excretion of copper by the rat: observations on their clinical significance. (1977) (10)
Computed Tomography of the Liver in Wilson Disease (1984) (10)
Hudson memorial lecture: Wilson's disease: Genetics and biochemistry—their relevance to therapy (1983) (10)
USE OF APOMORPHINE TO TEST FOR DOPAMINE RESPONSIVENESS IN WILSON'S DISEASE (1989) (10)
Thiomolybdates in the treatment of Wilson's disease. (1992) (9)
Chirality of penicillamine (1992) (9)
Corrigendum: The Wilson disease gene: spectrum of mutations and their consequences (1995) (9)
Primary Carcinoma of the Liver: Description of a Case with Ethanolaminuria, A New and Obscure Metabolic Defect (1953) (9)
The eye in Wilson disease. (2011) (9)
Letter: Treatment of Wilson's disease. (1975) (9)
The action of chelating agents in Wilson's disease. (1959) (9)
Acute Liver Disease (1950) (9)
PENICILLAMINE AND MIXED DISULPHIDE EXCRETION IN WILSON'S DISEASE. (1963) (8)
Hepatic Wilson’s disease: Initial treatment and long-term management (2005) (8)
Copper Metabolism and the Liver (1963) (8)
Unithiol in Wilson's disease (1985) (8)
Penicillamine and Nephrotoxicity (1962) (7)
Amino‐Acid Metabolism in Liver Disease (2008) (7)
The influence of genetic and acquired liver defects on radio-copper turnover in Wilson's disease. (1969) (7)
FILTERABLE AND NON-FILTERABLE SERUM COPPER. 1. THE ACTION OF PENICILLAMINE. (1963) (7)
Wilson disease: a most unusual patient. (2016) (7)
Surviving Wilson's disease. (2001) (7)
Changing concepts of the pathogenesis of Wilson's disease. (1959) (7)
BLEEDING ŒSOPHAGEAL VARICES IN PATIENTS WITH WILSON'S DISEASE (1970) (7)
[Hepatolenticular degeneration (Wilson's disease); unsolved problems]. (1962) (6)
Penicillamine-induced Arthropathy in Wilson's Disease (1977) (6)
Studies with radiocopper (64Cu) in Wilson's disease: dynamics of copper transport. (1965) (6)
FILTERABLE AND NON-FILTERABLE SERUM COPPER. (2). STUDIES WITH 64CU. (1964) (6)
The discovery of the therapeutic use of D-penicillamine. (1981) (6)
The Biochemistry of Copper in Man and Its Role in the Pathogenesis of Wilson’s Disease (Hepatolenticular Degeneration) (1972) (5)
TETRAHYDROAMINOACRIDINE AND ALZHEIMER'S DISEASE (1987) (5)
The Effect of Chelation Therapy on the Amino Aciduria and Peptiduria of Wilson's Disease (1983) (5)
Carbohydrate intermediates in hepatic cirrhosis: role of lipoic acid. (1961) (5)
Pyruvate metabolism in Wilson's disease. (1961) (4)
Some factors influencing cerebral ammonia production in relation to hepatic coma. (1958) (4)
Letter: Missed Wilson's disease. (1975) (4)
Some factors influencing cerebral oxidation in relation to hepatic coma. (1958) (4)
WILSONS DISEASE–AN ANALYSIS OF THE CRANIAL COMPUTERIZED TOMOGRAPHIC APPEARANCES FOUND IN 60 PATIENTS AND THE CHANGES IN RESPONSE TO TREATMENT WITH CHELATING AGENTS (1982) (4)
CONGENITAL CUTIS LAXA AND MATERNAL D-PENICILLAMINE (1979) (4)
NATURAL HISTORY OF WILSON'S DISEASE (1967) (4)
WILSON'S DISEASE AND CHRONIC ACTIVE HEPATITIS (1977) (4)
DARKNESS OUT OF LIGHT (1962) (4)
Wilson's Disease, vol. 30 in the series Major Problems in Neurology. By Tjaard Hoogenraad. London, Philadelphia, Toronto, Sydney, Tokyo: W. B. Saunders. Co Ltd. Pp. 209. £45.00. (1997) (3)
A study of hepatic function in man before and after partial resection of liver. (1951) (3)
PANCREATIC DISTORTION DUE TO SPLENOMEGALY IN WILSON'S DISEASE (1983) (3)
Simultaneous use of two radioisotopes of copper (64Cu and 67Cu) in the study of copper turnover in man. (1969) (3)
Prevention of Wilson's disease (1989) (3)
Bleeding oesophageal varices in patients with Wilson's disease. (1970) (3)
Triethylene tetramine. (1970) (3)
The Kayser-Fleischer ring. (2014) (3)
PENICILLAMINE AND PYRIDOXINE IN MAN (1966) (2)
The management of rare diseases. (2006) (2)
Wilson's Disease: Gall Stone Copper following Liver Transplantation (1998) (2)
Management of rare diseases. (2006) (2)
Treatment of Cystinuria (1964) (2)
Hepatic Coma (1956) (2)
The liver and the brain. (1961) (2)
Effect of Chelating Agents on the Copper–Protein Bond in Liver (1963) (2)
Copper: Not Too Little, Not Too Much, but Just Right (1995) (2)
The Birth of an Idea (2009) (1)
Wilson's Disease, I.H. Scheinberg, I. Sternlieb, in: Major Problems in Internal Medicine, Vol. 23. Albert Einstein College of Medicine, Philadelphia, PA (1984), £ 34.50, available from Holt-Saunders, Ltd., 1 St. Anne's Road, Eastbourne, East Sussex BN21 3UN. (1985) (1)
PENICILLAMINE-INDUCED SLE (1981) (1)
POINTS FROM LETTERS: Caeruloplasmin in Wilson's Disease (1961) (1)
Peptiduria in the Fanconi syndrome. (1977) (1)
PENICILLAMINE AND DIMERCAPROL (1958) (1)
Treatment of hepatic encephalopathy. Authors' reply (2005) (1)
WILSON'S DISEASE. BIRTH DEFECTS (1971) (1)
Amino-acid metabolism. (1954) (1)
Ethanolaminuria; an obscure metabolic defect associated with a case of primary hepatoma. (1951) (1)
CURRENT THERAPEUTICS. 192. PENICILLAMINE. (1963) (1)
Penicillamine and Cystinuria (1963) (1)
Chirality of penicilamine (1992) (1)
DISTURBANCES OF AMINOACID METABOLISM FOLLOWING LIVER INJURY1 (1953) (1)
Health Orphans: The Academic Viewpoint (1988) (1)
Biochemical studies in hepatic coma. (1958) (1)
Methyl mercaptan in relation to foetor hepaticus. (1954) (0)
Copper dynamics in Wilson's disease. (1972) (0)
The Department of Experimental Medicine (2009) (0)
Primary Hepatic Lymphoma. (2005) (0)
Penicillamine: the pharmacology of a chelating agent. (1960) (0)
Prophylcatic use of penicillamine. (1968) (0)
Copper: Quest for a Cure (2018) (0)
The Causes of Epilepsy: Wilson disease (2011) (0)
Book Review: Wilson's Disease (1986) (0)
[Lactic and pyruvic acids in liver cirrhosis before and after the oral administration of glucose. Influence of thioctic acid on such acids]. (1959) (0)
EFFECTOF PENICILLAMINEON SERUM IRON (1965) (0)
154 The importance of molecular diagnosis for Wilson disease (2003) (0)
Liver failure and its treatment. (1956) (0)
Familial benign copper deficiency (1983) (0)
Hepatolenticular degeneration (Wilson's disease). (1957) (0)
WILSON DISEASE IN CHILDREN: MUTATIONS AND THEIR CONSEQUENCES • 845 (1996) (0)
Hepatic Function Before and After Resection of Liver (1951) (0)
THE PATHOGENESIS OF CYSTINURIA. II. POLAROGRAPHIC STUDIES OF THE METABOLISM OF SULPHUR-CON- (0)
EVERYTHING IS IMPORTANT (2016) (0)
Going International and yet more Problems (2009) (0)
April 1963 WALSHE : Copper Metabolism and the Liver (0)
The Wilson disease gene: Haplotypes and mutations (1994) (0)
New Ideas in Chelation Therapy (2010) (0)
a in rheumatoid arthritis. Its relationship to corticosteroid therapy and osteoporosis. (0)
Progress Despite Bureaucracy (2009) (0)
PRESYMPTOMATIC WILSON'S DISEASE (1967) (0)
10. Single photon emission tomography (SPET) in the assessment of patients with Wilson??s disease (1994) (0)
The End of a Strained Relationship (2009) (0)
Magnetic resonance spectroscopy of patients with Wilson's disease (2001) (0)
Wilson Disease (2019) (0)
WILSON'S DISEASE AND CONTROLLER GENE MUTATION (1981) (0)
SERUM FROM WILSON'S DISEASE WANTED (1961) (0)
A ring precipitin test in chronic liver disease: a study of the false positive. (1961) (0)
WALSHE AND PATSTON TABLE SERUM IRON AND COPPER LEVELS AFTER PENICILLAMINE Age at Months Terst (2007) (0)
Lactic and pyruvic acid in cirrhosis of the liver before and after administration of glucose by mouth. Effect of thioctic acid on these acids. (1959) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With John M. Walshe?

John M. Walshe is affiliated with the following schools:

University of Cambridge

John M. Walshe's Academic­Influence.com Rankings

John M. Walshe's Degrees

Why Is John M. Walshe Influential?

John M. Walshe's Published Works

Published Works

What Schools Are Affiliated With John M. Walshe?

John M. Walshe's AcademicInfluence.com Rankings